{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:22:05Z","timestamp":1794212525356,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI160706"],"award-info":[{"award-number":["R01AI160706"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI176069"],"award-info":[{"award-number":["R21AI176069"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI180874"],"award-info":[{"award-number":["R21AI180874"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00014"],"award-info":[{"award-number":["75N93021C00014"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00046"],"award-info":[{"award-number":["75N93019C00046"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI22C2101"],"award-info":[{"award-number":["HI22C2101"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parenteral vaccines against respiratory viruses poorly block infection and transmission due to suboptimal induction of mucosal immunity. In contrast, hybrid immunity and heterologous-route immunization regimens generate protective mucosal and systemic immunity. Herein, we examine how chronological order in heterologous prime\/boost immunization regimens impacts immune responses using combinations of intramuscular mRNA and intranasal adjuvanted subunit vaccines against SARS-CoV-2. Enhanced long-lived mucosal and systemic immunity depended strongly on vaccine delivery sequence, with heterologous regimens administered in alternate order of routes yielding markedly distinct immune profiles with different Th-biases and divergent localizations. Immunity imparted through heterologous immunization was more durable and responsive to delayed boosting than parenteral-only regimens. Furthermore, intramuscular mRNA immunization uniquely shaped gene expression locally and systemically through IFN-I induction, allowing for enhanced responses to subsequent mucosal immunizations. These findings demonstrate that the context of initial antigen exposure\u2014including the route of exposure and associated inflammatory signals\u2014profoundly shapes responses to subsequent encounters. Thus, vaccine responses in antigen-experienced hosts differ fundamentally from those induced on a naive baseline, reflecting the influence of pre-existing innate and adaptive immune memory.<\/jats:p>","DOI":"10.1038\/s44321-026-00539-w","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:03:33Z","timestamp":1791806613000},"page":"4585-4617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatiotemporal heterologous vaccination relies on type I interferons at priming to enhance mucosal immunity"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7360-638X","authenticated-orcid":false,"given":"Matthew J","family":"Wiest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7928-984X","authenticated-orcid":false,"given":"Gabriel","family":"Laghlali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1913-1613","authenticated-orcid":false,"given":"Julianne","family":"d\u2019Acunzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinghan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz","family":"Noureddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna W","family":"Janczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Farazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J","family":"O\u2019Konek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-1827","authenticated-orcid":false,"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-1932","authenticated-orcid":false,"suffix":"Jr","given":"James R","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-3132","authenticated-orcid":false,"given":"Michael","family":"Schotsaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-4723","authenticated-orcid":false,"given":"Pamela T","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"539_CR1","first-page":"478","volume":"32","author":"M Andreoni","year":"2024","unstructured":"Andreoni M, Bonanni P, Gabutti G, Maggi S, Siliquini R, Ungar A (2024) RSV vaccination as the optimal prevention strategy for older adults. Infez Med 32:478\u2013488","journal-title":"Infez Med"},{"key":"539_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","volume":"596","author":"PS Arunachalam","year":"2021","unstructured":"Arunachalam PS, Scott MKD, Hagan T, Li C, Feng Y, Wimmers F, Grigoryan L, Trisal M, Edara VV, Lai L et al (2021) Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 596:410\u2013416","journal-title":"Nature"},{"key":"539_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2022.05.002","volume":"150","author":"JR Baker","year":"2022","unstructured":"Baker JR, Farazuddin M, Wong PT, O\u2019Konek JJ (2022) The unfulfilled potential of mucosal immunization. J Allergy Clin Immunol 150:1\u201311","journal-title":"J Allergy Clin Immunol"},{"key":"539_CR4","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","volume":"27","author":"J Barros-Martins","year":"2021","unstructured":"Barros-Martins J, Hammerschmidt SI, Cossmann A, Odak I, Stankov MV, Morillas Ramos G, Dopfer-Jablonka A, Heidemann A, Ritter C, Friedrichsen M et al (2021) Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination. Nat Med 27:1525\u20131529","journal-title":"Nat Med"},{"key":"539_CR5","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1084\/jem.20181365","volume":"216","author":"LK Beura","year":"2019","unstructured":"Beura LK, Fares-Frederickson NJ, Steinert EM, Scott MC, Thompson EA, Fraser KA, Schenkel JM, Vezys V, Masopust D (2019) CD4+ resident memory T cells dominate immunosurveillance and orchestrate local recall responses. J Exp Med 216:1214\u20131229","journal-title":"J Exp Med"},{"key":"539_CR6","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.4049\/jimmunol.1301424","volume":"192","author":"AU Bielinska","year":"2014","unstructured":"Bielinska AU, Makidon PE, Janczak KW, Blanco LP, Swanson B, Smith DM, Pham T, Szabo Z, Kukowska-Latallo JF, Baker JR (2014) Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant. J Immunol 192:2722\u20132733","journal-title":"J Immunol"},{"key":"539_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","volume":"23","author":"N Bobrovitz","year":"2023","unstructured":"Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H et al (2023) Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis 23:556\u2013567","journal-title":"Lancet Infect Dis"},{"key":"539_CR8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41385-021-00407-5","volume":"14","author":"L Borkner","year":"2021","unstructured":"Borkner L, Curham LM, Wilk MM, Moran B, Mills KHG (2021) IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol 14:1183\u20131202","journal-title":"Mucosal Immunol"},{"key":"539_CR9","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1016\/j.cell.2025.11.023","volume":"188","author":"D Casta\u00f1o","year":"2025","unstructured":"Casta\u00f1o D, Bettini E, Kumar B, Chudnovskiy A, Siv A, Protti G, Nakadakari-Higa S, Ceglia S, De Luna N, Chiu JE et al (2025) Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses. Cell 188:7461\u20137480.e23","journal-title":"Cell"},{"key":"539_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01227-5","volume":"10","author":"C Chen","year":"2025","unstructured":"Chen C, Benson OE, Simmons T, Dorsett CL, Janczak KW, Wiest MJ, Farazuddin M, Baker JR, Wong PT, O\u2019Konek JJ (2025) Rational adjuvant selection for the neonatal period shapes unique and lasting immune polarization in mice. NPJ Vaccines 10:165","journal-title":"NPJ Vaccines"},{"key":"539_CR11","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/eji.202249823","volume":"52","author":"M Cokari\u0107 Brdov\u010dak","year":"2022","unstructured":"Cokari\u0107 Brdov\u010dak M, Materljan J, \u0160usti\u0107 M, Ravli\u0107 S, Ru\u017ei\u0107 T, Lisni\u0107 B, Mikli\u0107 K, Brizi\u0107 I, Pribani\u0107 Mate\u0161i\u0107 M, Jurani\u0107 Lisni\u0107 V et al (2022) ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination. Eur J Immunol 52:936\u2013945","journal-title":"Eur J Immunol"},{"key":"539_CR12","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMc2115596","volume":"385","author":"A-RY Collier","year":"2021","unstructured":"Collier A-RY, Yu J, McMahan K, Liu J, Chandrashekar A, Maron JS, Atyeo C, Martinez DR, Ansel JL, Aguayo R et al (2021) Differential kinetics of immune responses elicited by covid-19 vaccines. N Engl J Med 385:2010\u20132012","journal-title":"N Engl J Med"},{"key":"539_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148546","volume":"132","author":"M Corrado","year":"2022","unstructured":"Corrado M, Pearce EL (2022) Targeting memory T cell metabolism to improve immunity. J Clin Invest 132:e148546","journal-title":"J Clin Invest"},{"key":"539_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41590-024-02036-z","volume":"26","author":"M Cortese","year":"2025","unstructured":"Cortese M, Hagan T, Rouphael N, Wu S-Y, Xie X, Kazmin D, Wimmers F, Gupta S, van der Most R, Coccia M et al (2025) System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans. Nat Immunol 26:116\u2013130","journal-title":"Nat Immunol"},{"key":"539_CR15","doi-asserted-by":"publisher","first-page":"932388","DOI":"10.3389\/fimmu.2022.932388","volume":"13","author":"MW Dahlgren","year":"2022","unstructured":"Dahlgren MW, Plumb AW, Niss K, Lahl K, Brunak S, Johansson-Lindbom B (2022) Type I interferons promote germinal centers through B cell intrinsic signaling and dendritic cell dependent Th1 and Tfh cell lineages. Front Immunol 13:932388","journal-title":"Front Immunol"},{"key":"539_CR16","doi-asserted-by":"publisher","first-page":"112167","DOI":"10.1016\/j.celrep.2023.112167","volume":"42","author":"T Dangi","year":"2023","unstructured":"Dangi T, Sanchez S, Lew MH, Awakoaiye B, Visvabharathy L, Richner JM, Koralnik IJ, Penaloza-MacMaster P (2023) Pre-existing immunity modulates responses to mRNA boosters. Cell Rep 42:112167","journal-title":"Cell Rep"},{"key":"539_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50087-5","volume":"15","author":"C Dong","year":"2024","unstructured":"Dong C, Zhu W, Wei L, Kim JK, Ma Y, Kang S-M, Wang B-Z (2024a) Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nat Commun 15:5800","journal-title":"Nat Commun"},{"key":"539_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50087-5","volume":"15","author":"C Dong","year":"2024","unstructured":"Dong C, Zhu W, Wei L, Kim JK, Ma Y, Kang S-M, Wang B-Z (2024b) Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nat Commun 15:5800","journal-title":"Nat Commun"},{"key":"539_CR19","doi-asserted-by":"publisher","first-page":"eabn8057","DOI":"10.1126\/scitranslmed.abn8057","volume":"14","author":"JP Evans","year":"2022","unstructured":"Evans JP, Zeng C, Carlin C, Lozanski G, Saif LJ, Oltz EM, Gumina RJ, Liu S-L (2022) Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Sci Transl Med 14:eabn8057","journal-title":"Sci Transl Med"},{"key":"539_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj8526","volume":"9","author":"SL Gray-Gaillard","year":"2024","unstructured":"Gray-Gaillard SL, Solis SM, Chen HM, Monteiro C, Ciabattoni G, Samanovic MI, Cornelius AR, Williams T, Geesey E, Rodriguez M et al (2024) SARS-CoV-2 inflammation durably imprints memory CD4 T cells. Sci Immunol 9:eadj8526","journal-title":"Sci Immunol"},{"key":"539_CR21","doi-asserted-by":"crossref","unstructured":"Hall JM, Guti\u00e9rrez-Ferman JL, Shamseldin MM, Guo M, Gupta YA, Deora R, Dubey P (2024) Opposing effects of acellular and whole cell pertussis vaccines on Bordetella pertussis biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2024.01.23.576795v1","DOI":"10.1101\/2024.01.23.576795"},{"key":"539_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","volume":"183","author":"AO Hassan","year":"2020","unstructured":"Hassan AO, Kafai NM, Dmitriev IP, Fox JM, Smith BK, Harvey IB, Chen RE, Winkler ES, Wessel AW, Case JB et al (2020) A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell 183:169\u2013184.e13","journal-title":"Cell"},{"key":"539_CR23","doi-asserted-by":"publisher","first-page":"1039194","DOI":"10.3389\/fimmu.2022.1039194","volume":"13","author":"M Hassert","year":"2022","unstructured":"Hassert M, Harty JT (2022) Tissue resident memory T cells\u2014a new benchmark for the induction of vaccine-induced mucosal immunity. Front Immunol 13:1039194","journal-title":"Front Immunol"},{"key":"539_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","volume":"73","author":"MJ Hogan","year":"2022","unstructured":"Hogan MJ, Pardi N (2022) mRNA Vaccines in the COVID-19 Pandemic and Beyond. Annu Rev Med 73:17\u201339","journal-title":"Annu Rev Med"},{"key":"539_CR25","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"C-L Hsieh","year":"2020","unstructured":"Hsieh C-L, Goldsmith JA, Schaub JM, DiVenere AM, Kuo H-C, Javanmardi K, Le KC, Wrapp D, Lee AG, Liu Y et al (2020) Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369:1501\u20131505","journal-title":"Science"},{"key":"539_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00691-1","volume":"8","author":"S Jangra","year":"2023","unstructured":"Jangra S, Landers JJ, Laghlali G, Rathnasinghe R, Warang P, Park S-C, O\u2019Konek JJ, Singh G, Janczak KW, Garc\u00eda-Sastre A et al (2023) Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice. NPJ Vaccines 8:96","journal-title":"NPJ Vaccines"},{"key":"539_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729189","volume":"12","author":"S Jangra","year":"2021","unstructured":"Jangra S, Landers JJ, Rathnasinghe R, O\u2019Konek JJ, Janczak KW, Cascalho M, Kennedy AA, Tai AW, Baker JR, Schotsaert M et al (2021) A combination adjuvant for the induction of potent antiviral immune responses for a recombinant SARS-CoV-2 protein vaccine. Front Immunol 12:729189","journal-title":"Front Immunol"},{"key":"539_CR28","doi-asserted-by":"publisher","first-page":"e798","DOI":"10.1016\/S2214-109X(22)00112-7","volume":"10","author":"A Jara","year":"2022","unstructured":"Jara A, Undurraga EA, Zubizarreta JR, Gonz\u00e1lez C, Pizarro A, Acevedo J, Leo K, Paredes F, Bralic T, Vergara V et al (2022) Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study. Lancet Glob Health 10:e798\u2013e806","journal-title":"Lancet Glob Health"},{"key":"539_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba6006","volume":"13","author":"V Kalia","year":"2021","unstructured":"Kalia V, Yuzefpolskiy Y, Vegaraju A, Xiao H, Baumann F, Jatav S, Church C, Prlic M, Jha A, Nghiem P et al (2021) Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice. Sci Transl Med 13:eaba6006","journal-title":"Sci Transl Med"},{"key":"539_CR30","doi-asserted-by":"publisher","first-page":"e1005754","DOI":"10.1371\/journal.ppat.1005754","volume":"12","author":"M Kandasamy","year":"2016","unstructured":"Kandasamy M, Suryawanshi A, Tundup S, Perez JT, Schmolke M, Manicassamy S, Manicassamy B (2016) RIG-I signaling is critical for efficient polyfunctional T cell responses during influenza virus infection. PLoS Pathog 12:e1005754","journal-title":"PLoS Pathog"},{"key":"539_CR31","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41590-025-02156-0","volume":"26","author":"D-I Kwon","year":"2025","unstructured":"Kwon D-I, Mao T, Israelow B, Santos Guedes de S\u00e1 K, Dong H, Iwasaki A (2025) Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice. Nat Immunol 26:908\u2013919","journal-title":"Nat Immunol"},{"key":"539_CR32","doi-asserted-by":"crossref","unstructured":"Laghlali G, Wiest MJ, Karadag D, Warang P, O'Konek JJ, Chang LA, Park SC, Yan V, Farazuddin M, Janczak KW et al (2024) Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime\/intranasal protein boost vaccination with a combination adjuvant. Mol Ther 32: 4448\u20134466","DOI":"10.1016\/j.ymthe.2024.10.016"},{"key":"539_CR33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.immuni.2024.03.015","volume":"57","author":"EC Lavelle","year":"2024","unstructured":"Lavelle EC, McEntee CP (2024) Vaccine adjuvants: tailoring innate recognition to send the right message. Immunity 57:772\u2013789","journal-title":"Immunity"},{"key":"539_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","volume":"22","author":"EC Lavelle","year":"2022","unstructured":"Lavelle EC, Ward RW (2022) Mucosal vaccines\u2014fortifying the frontiers. Nat Rev Immunol 22:236\u2013250","journal-title":"Nat Rev Immunol"},{"key":"539_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","volume":"23","author":"C Li","year":"2022","unstructured":"Li C, Lee A, Grigoryan L, Arunachalam PS, Scott MKD, Trisal M, Wimmers F, Sanyal M, Weidenbacher PA, Feng Y et al (2022) Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat Immunol 23:543\u2013555","journal-title":"Nat Immunol"},{"key":"539_CR36","doi-asserted-by":"publisher","first-page":"1216402","DOI":"10.3389\/fimmu.2023.1216402","volume":"14","author":"S Longet","year":"2023","unstructured":"Longet S, Paul S (2023) Pivotal role of tissue-resident memory lymphocytes in the control of mucosal infections: can mucosal vaccination induce protective tissue-resident memory T and B cells? Front Immunol 14:1216402","journal-title":"Front Immunol"},{"key":"539_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2110105119","volume":"119","author":"M Lu","year":"2022","unstructured":"Lu M, Chamblee M, Zhang Y, Ye C, Dravid P, Park J-G, Mahesh KC, Trivedi S, Murthy S, Sharma H et al (2022) SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern. Proc Natl Acad Sci USA 119:e2110105119","journal-title":"Proc Natl Acad Sci USA"},{"key":"539_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","volume":"21","author":"S Lu","year":"2009","unstructured":"Lu S (2009) Heterologous prime-boost vaccination. Curr Opin Immunol 21:346\u2013351","journal-title":"Curr Opin Immunol"},{"key":"539_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo2523","volume":"378","author":"T Mao","year":"2022","unstructured":"Mao T, Israelow B, Pe\u00f1a-Hern\u00e1ndez MA, Suberi A, Zhou L, Luyten S, Reschke M, Dong H, Homer RJ, Saltzman WM et al (2022) Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses. Science 378:eabo2523","journal-title":"Science"},{"key":"539_CR40","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/JVI.02338-12","volume":"87","author":"L Mart\u00ednez-Gil","year":"2013","unstructured":"Mart\u00ednez-Gil L, Goff PH, Hai R, Garc\u00eda-Sastre A, Shaw ML, Palese P (2013) A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant. J Virol 87:1290\u20131300","journal-title":"J Virol"},{"key":"539_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1574-695X.2002.tb00551.x","volume":"32","author":"MJ McCluskie","year":"2002","unstructured":"McCluskie MJ, Weeratna RD, Payette PJ, Davis HL (2002) Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. FEMS Immunol Med Microbiol 32:179\u2013185","journal-title":"FEMS Immunol Med Microbiol"},{"key":"539_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-023-06951-3","volume":"626","author":"K McMahan","year":"2024","unstructured":"McMahan K, Wegmann F, Aid M, Sciacca M, Liu J, Hachmann NP, Miller J, Jacob-Dolan C, Powers O, Hope D et al (2024) Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques. Nature 626:385\u2013391","journal-title":"Nature"},{"key":"539_CR43","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.ymthe.2024.04.019","volume":"32","author":"B Montoya","year":"2024","unstructured":"Montoya B, Melo-Silva CR, Tang L, Kafle S, Lidskiy P, Bajusz C, Vadovics M, Muramatsu H, Abraham E, Lipinszki Z et al (2024) mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies. Mol Ther 32:1790\u20131804","journal-title":"Mol Ther"},{"key":"539_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1086\/314952","volume":"180","author":"TM Moran","year":"1999","unstructured":"Moran TM, Park H, Fernandez-Sesma A, Schulman JL (1999) Th2 responses to inactivated influenza virus can be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. J Infect Dis 180:579\u2013585","journal-title":"J Infect Dis"},{"key":"539_CR45","doi-asserted-by":"publisher","first-page":"e72619","DOI":"10.7554\/eLife.72619","volume":"10","author":"J Neidleman","year":"2021","unstructured":"Neidleman J, Luo X, McGregor M, Xie G, Murray V, Greene WC, Lee SA, Roan NR (2021) mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. eLife 10:e72619","journal-title":"eLife"},{"key":"539_CR46","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/jmv.27688","volume":"94","author":"KI Notarte","year":"2022","unstructured":"Notarte KI, Guerrero-Arguero I, Velasco JV, Ver AT, Santos de Oliveira MH, Catahay JA, Khan MSR, Pastrana A, Juszczyk G, Torrelles JB et al (2022) Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: a systematic review. J Med Virol 94:2939\u20132961","journal-title":"J Med Virol"},{"key":"539_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19891-7","volume":"11","author":"FS Oladunni","year":"2020","unstructured":"Oladunni FS, Park J-G, Pino PA, Gonzalez O, Akhter A, Allu\u00e9-Guardia A, Olmo-Font\u00e1nez A, Gautam S, Garcia-Vilanova A, Ye C et al (2020) Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat Commun 11:6122","journal-title":"Nat Commun"},{"key":"539_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"X Ou","year":"2020","unstructured":"Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J et al (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11:1620","journal-title":"Nat Commun"},{"key":"539_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-026-01383-2","volume":"11","author":"Z Pan","year":"2026","unstructured":"Pan Z, Zheng X, Jiang L, Ding C, Liu Y, Peng H, Liu Y, He Y, Tang W, Zhang C et al (2026) Intranasal S-2P and lentinan formulation confers broad protection against SARS-CoV-2 VOCs via IFN-\u03b3-dominant mechanisms. NPJ Vaccines 11:60","journal-title":"NPJ Vaccines"},{"key":"539_CR50","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1016\/S0264-410X(03)00499-7","volume":"21","author":"S-H Park","year":"2003","unstructured":"Park S-H, Yang S-H, Lee CG, Youn J-W, Chang J, Sung YC (2003) Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost. Vaccine 21:4555\u20134564","journal-title":"Vaccine"},{"key":"539_CR51","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/embor.2013.102","volume":"14","author":"JR Patel","year":"2013","unstructured":"Patel JR, Jain A, Chou Y, Baum A, Ha T, Garc\u00eda-Sastre A (2013) ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO Rep 14:780\u2013787","journal-title":"EMBO Rep"},{"key":"539_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37559-w","volume":"14","author":"DKJ Pieren","year":"2023","unstructured":"Pieren DKJ, Kuguel SG, Rosado J, Robles AG, Rey-Cano J, Mancebo C, Esperalba J, Falc\u00f3 V, Buz\u00f3n MJ, Genesc\u00e0 M (2023) Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection. Nat Commun 14:1887","journal-title":"Nat Commun"},{"key":"539_CR53","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1172\/JCI96957","volume":"128","author":"A Pizzolla","year":"2018","unstructured":"Pizzolla A, Nguyen TH, Sant S, Jaffar J, Loudovaris T, Mannering SI, Thomas PG, Westall GP, Kedzierska K, Wakim LM (2018) Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest 128:721\u2013733","journal-title":"J Clin Invest"},{"key":"539_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aam6970","volume":"2","author":"A Pizzolla","year":"2017","unstructured":"Pizzolla A, Nguyen THO, Smith JM, Brooks AG, Kedzieska K, Heath WR, Reading PC, Wakim LM (2017a) Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection. Sci Immunol 2:eaam6970","journal-title":"Sci Immunol"},{"key":"539_CR55","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1073\/pnas.1620194114","volume":"114","author":"A Pizzolla","year":"2017","unstructured":"Pizzolla A, Wang Z, Groom JR, Kedzierska K, Brooks AG, Reading PC, Wakim LM (2017b) Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells. Proc Natl Acad Sci USA 114:5225\u20135230","journal-title":"Proc Natl Acad Sci USA"},{"key":"539_CR56","unstructured":"R Core Team (2022) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria"},{"key":"539_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26803-w","volume":"12","author":"P Radvak","year":"2021","unstructured":"Radvak P, Kwon H-J, Kosikova M, Ortega-Rodriguez U, Xiang R, Phue J-N, Shen R-F, Rozzelle J, Kapoor N, Rabara T et al (2021) SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains. Nat Commun 12:6559","journal-title":"Nat Commun"},{"key":"539_CR58","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1080\/22221751.2020.1838955","volume":"9","author":"R Rathnasinghe","year":"2020","unstructured":"Rathnasinghe R, Strohmeier S, Amanat F, Gillespie VL, Krammer F, Garc\u00eda-Sastre A, Coughlan L, Schotsaert M, Uccellini MB (2020) Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerg Microbes Infect 9:2433\u20132445","journal-title":"Emerg Microbes Infect"},{"key":"539_CR59","doi-asserted-by":"crossref","unstructured":"Roederer AL, Cao Y, St Denis K, Sheehan ML, Li CJ, Lam EC, Gregory DJ, Poznansky MC, Iafrate AJ, Canaday DH et al (2024) Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity. Cell Rep Med 5:101850","DOI":"10.1016\/j.xcrm.2024.101850"},{"key":"539_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder RA, Darrah PA, Roederer M (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8:247\u2013258","journal-title":"Nat Rev Immunol"},{"key":"539_CR61","doi-asserted-by":"publisher","first-page":"e1001304","DOI":"10.1371\/journal.ppat.1001304","volume":"7","author":"S-U Seo","year":"2011","unstructured":"Seo S-U, Kwon H-J, Ko H-J, Byun Y-H, Seong BL, Uematsu S, Akira S, Kweon M-N (2011) Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog 7:e1001304","journal-title":"PLoS Pathog"},{"key":"539_CR62","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature11522","volume":"491","author":"H Shin","year":"2012","unstructured":"Shin H, Iwasaki A (2012) A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491:463\u2013467","journal-title":"Nature"},{"key":"539_CR63","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature04606","volume":"440","author":"LR Shiow","year":"2006","unstructured":"Shiow LR, Rosen DB, Brdickov\u00e1 N, Xu Y, An J, Lanier LL, Cyster JG, Matloubian M (2006) CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440:540\u2013544","journal-title":"Nature"},{"key":"539_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105185","volume":"105","author":"S Slamanig","year":"2024","unstructured":"Slamanig S, Gonz\u00e1lez-Dom\u00ednguez I, Chang LA, Lemus N, Lai TY, Mart\u00ednez JL, Singh G, Dolange V, Abdeljawad A, Kowdle S et al (2024) Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice. EBioMedicine 105:105185","journal-title":"EBioMedicine"},{"key":"539_CR65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.vaccine.2011.10.094","volume":"30","author":"LR Stanberry","year":"2012","unstructured":"Stanberry LR, Simon JK, Johnson C, Robinson PL, Morry J, Flack MR, Gracon S, Myc A, Hamouda T, Baker JR (2012) Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens. Vaccine 30:307\u2013316","journal-title":"Vaccine"},{"key":"539_CR66","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.immuni.2021.03.005","volume":"54","author":"PA Szabo","year":"2021","unstructured":"Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, Krupska I, Matsumoto R, Poon MML, Idzikowski E et al (2021) Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 54:797\u2013814.e6","journal-title":"Immunity"},{"key":"539_CR67","doi-asserted-by":"publisher","first-page":"e2226335","DOI":"10.1001\/jamanetworkopen.2022.26335","volume":"5","author":"CS Tan","year":"2022","unstructured":"Tan CS, Collier A-RY, Yu J, Liu J, Chandrashekar A, McMahan K, Jacob-Dolan C, He X, Roy V, Hauser BM et al (2022) Durability of heterologous and homologous COVID-19 vaccine boosts. JAMA Netw Open 5:e2226335","journal-title":"JAMA Netw Open"},{"key":"539_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add4853","volume":"7","author":"J Tang","year":"2022","unstructured":"Tang J, Zeng C, Cox TM, Li C, Son YM, Cheon IS, Wu Y, Behl S, Taylor JJ, Chakaraborty R et al (2022) Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. Sci Immunol 7:eadd4853","journal-title":"Sci Immunol"},{"key":"539_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aeb2657","volume":"10","author":"LP Tavares","year":"2025","unstructured":"Tavares LP, Br\u00fcggemann TR, Cagnina RE, Nshimiyimana R, Villase\u00f1or-Altamirano AB, Rezende RM, Lanser TB, Liu X, Bateman ME, Krishnamoorthy N et al (2025) Siglec-F+ neutrophils promote the resolution of acute lung injury through ALOX15 induction. Sci Immunol 10:eaeb2657","journal-title":"Sci Immunol"},{"key":"539_CR70","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/vaccines9091033","volume":"9","author":"MN Uddin","year":"2021","unstructured":"Uddin MN, Roni MA (2021) Challenges of storage and stability of mRNA-based COVID-19 vaccines. Vaccines 9:1033","journal-title":"Vaccines"},{"key":"539_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101668","volume":"5","author":"WN Voss","year":"2024","unstructured":"Voss WN, Mallory MA, Byrne PO, Marchioni JM, Knudson SA, Powers JM, Leist SR, Dadonaite B, Townsend DR, Kain J et al (2024) Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination. Cell Rep Med 5:101668","journal-title":"Cell Rep Med"},{"key":"539_CR72","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1128\/jvi.70.5.2852-2860.1996","volume":"70","author":"ME Waris","year":"1996","unstructured":"Waris ME, Tsou C, Erdman DD, Zaki SR, Anderson LJ (1996) Respiratory synctial virus infection in BALB\/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J Virol 70:2852\u20132860","journal-title":"J Virol"},{"key":"539_CR73","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1021\/acs.molpharmaceut.0c00315","volume":"18","author":"PT Wong","year":"2021","unstructured":"Wong PT, Goff PH, Sun RJ, Ruge MJ, Ermler ME, Sebring A, O\u2019Konek JJ, Landers JJ, Janczak KW, Sun W et al (2021) Combined intranasal nanoemulsion and RIG-I activating RNA adjuvants enhance mucosal, humoral, and cellular immunity to influenza virus. Mol Pharm 18:679\u2013698","journal-title":"Mol Pharm"},{"key":"539_CR74","doi-asserted-by":"publisher","first-page":"e0126120","DOI":"10.1371\/journal.pone.0126120","volume":"10","author":"PT Wong","year":"2015","unstructured":"Wong PT, Leroueil PR, Smith DM, Ciotti S, Bielinska AU, Janczak KW, Mullen CH, Groom JV, Taylor EM, Passmore C et al (2015) Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants. PLoS ONE 10:e0126120","journal-title":"PLoS ONE"},{"key":"539_CR75","doi-asserted-by":"publisher","first-page":"2364519","DOI":"10.1080\/21645515.2024.2364519","volume":"20","author":"H Yang","year":"2024","unstructured":"Yang H, Xie Y, Li S, Bao C, Wang J, Li C, Nie J, Quan Y (2024) Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice. Hum Vaccin Immunother 20:2364519","journal-title":"Hum Vaccin Immunother"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00539-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00539-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00539-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:32:42Z","timestamp":1794209562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00539-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":75,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11,9]]}},"alternative-id":["539"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00539-w","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PW, MS, AG-S, and JB are co-inventors on patents for NE\/IVT. The M.S. laboratory received unrelated research support as sponsored research agreements from ArgenX BV, Phio Pharmaceuticals, 7Hills Pharma LLC, Ziphius, and Moderna. AG-S has received research support from GSK, Pfizer, Senhwa Biosciences, Kenall Manufacturing, Blade Therapeutics, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma, Applied Biological Laboratories, and Merck, outside of the reported work. AG-S has consulting agreements with the following companies involving cash and\/or stock: Castlevax, Amovir, Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, CureLab Oncology, CureLab Veterinary, Synairgen, SimpleParatus, Pfizer, and Prosetta, outside of the reported work. AG-S has been an invited speaker at meeting events organized by Seqirus, Janssen, Abbott, and Astrazeneca. AG-S is the inventor of patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections and cancer, owned by the Icahn School of Medicine at Mount Sinai, New York. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}